Search Results

Agricola

Record details

Overcoming Chemoimmunotherapy-Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension.

• Authors : Jin SM; SKKU Advanced Institute of Nanotechnology (SAINT), Department of Nano Engineering and School of Chemical Engineering, Sungkyunkwan University (SKKU), 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of Korea.; Lee SN

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*immunology ; Immunosuppression Therapy/Immunosuppression Therapy/Immunosuppression Therapy/*methods

• Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2021 Oct; Vol. 8 (19), pp. e2102043. Date of Electronic Publication: 2021 Aug 07.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion.

• Authors : Wang M; Department of Neurosurgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.; Jia J

Subjects: 5'-Nucleotidase/5'-Nucleotidase/5'-Nucleotidase/*metabolism ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*immunology ; Extracellular Vesicles/Extracellular Vesicles/Extracellular Vesicles/*immunology

• Source: Cell death & disease [Cell Death Dis] 2021 Nov 09; Vol. 12 (11), pp. 1065. Date of Electronic Publication: 2021 Nov 09.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Targeting immunosuppression by TGF-β1 for cancer immunotherapy.

• Authors : de Streel G; de Duve Institute, Université catholique de Louvain, 1200 Brussels, Belgium.; Lucas S

Subjects: Immunity, Cellular/Immunity, Cellular/Immunity, Cellular/*immunology ; Immunosuppression Therapy/Immunosuppression Therapy/Immunosuppression Therapy/*methods ; Immunotherapy/Immunotherapy/Immunotherapy/*methods

• Source: Biochemical pharmacology [Biochem Pharmacol] 2021 Oct; Vol. 192, pp. 114697. Date of Electronic Publication: 2021 Jul 22.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.

• Authors : Jan CI; Department of Pathology, China Medical University Hospital, Taichung, Taiwan.; Department of Medicine, China Medical University, Taichung, Taiwan.

Subjects: Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*immunology ; HLA Antigens/HLA Antigens/HLA Antigens/*metabolism ; Immunosuppression Therapy/Immunosuppression Therapy/Immunosuppression Therapy/*methods

• Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Oct; Vol. 9 (10).Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy.

• Authors : Steingold JM; Department of Pharmaceutical Sciences, New England Inflammation and Tissue Protection Institute, Bouvé College of Health Sciences, Northeastern University, Boston, MA, United States.; Hatfield SM

Subjects: Immunosuppression Therapy*/Immunosuppression Therapy*/Immunosuppression Therapy*/methods ; Immunotherapy*; Hypoxia/Hypoxia/Hypoxia/*metabolism

• Source: Frontiers in immunology [Front Immunol] 2020 Sep 29; Vol. 11, pp. 570041. Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Agricola

Record details

Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1.

• Authors : Zhu D; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Life Sciences, Peking University, Beijing, China.

Subjects: Cysteine Endopeptidases/Cysteine Endopeptidases/Cysteine Endopeptidases/*metabolism ; Deubiquitinating Enzymes/Deubiquitinating Enzymes/Deubiquitinating Enzymes/*metabolism ; Immunosuppression Therapy/Immunosuppression Therapy/Immunosuppression Therapy/*methods

• Source: Cell death and differentiation [Cell Death Differ] 2021 Jun; Vol. 28 (6), pp. 1773-1789. Date of Electronic Publication: 2020 Dec 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy.

• Authors : Fu Z; Malaghan Institute of Medical Research, Wellington 6042, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, University of Auckland, Auckland 1142, New Zealand.

Subjects: Tumor Microenvironment*; Immunity/Immunity/Immunity/*immunology ; Immunosuppression Therapy/Immunosuppression Therapy/Immunosuppression Therapy/*methods

• Source: Cells [Cells] 2021 Apr 24; Vol. 10 (5). Date of Electronic Publication: 2021 Apr 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details